Univest
Univest
  • Markets

Arunjyoti Bio Ventures Q4 FY26 Results: Revenue Rs 7.24 Crore Up 37.04 Percent YoY

  • May 14, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Arunjyoti Bio Ventures Q4 FY26 Results

Arunjyoti Bio Ventures Q4 FY26 standalone net sales were Rs 7.24 crore, up 37.04% YoY from approximately Rs 5.28 crore in Q4 FY25. The company develops and markets biofertilizers and biopesticides for agricultural use, benefiting from rising demand for sustainable farming inputs. Investors tracking Arunjyoti Bio Ventures Q4 FY26 results will find detailed analysis and insights in this article.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Arunjyoti Bio Ventures Q4 FY26 Key Financial Highlights
  • Arunjyoti Bio Ventures Q4 FY26 Performance Analysis
  • Arunjyoti Bio Ventures FY27 Outlook
  • Frequently Asked Questions on Arunjyoti Bio Ventures Q4 FY26 Results
    • When did Arunjyoti Bio Ventures announce Q4 FY26 results?
    • What are the key highlights of Arunjyoti Bio Ventures Q4 FY26?
    • Where can I track Arunjyoti Bio Ventures Q4 FY26 live data?

Arunjyoti Bio Ventures Q4 FY26 Key Financial Highlights

Metric Q4 FY26 Reference / YoY
Revenue (Net Sales) Rs 7.24 crore Rs 5.28 crore (Q4 FY25) | +37.04% YoY
NSE/BSE Ticker ARUNJYOTI Sector: Agricultural Biotechnology

Screen the best stocks on the Univest Screener.

Arunjyoti Bio Ventures Q4 FY26 Performance Analysis

The Arunjyoti Bio Ventures Q4 FY26 results reflect the company’s performance in the Agricultural Biotechnology sector for the quarter ended March 31, 2026. Investors and analysts will closely monitor FY27 guidance and management commentary following these Arunjyoti Bio Ventures Q4 FY26 results.

Arunjyoti Bio Ventures FY27 Outlook

Post Arunjyoti Bio Ventures Q4 FY26 results, investor focus will be on FY27 revenue outlook, margin trajectory, order wins, and sector tailwinds. Track live price, analyst ratings, and earnings updates on the Univest Screener.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on Arunjyoti Bio Ventures Q4 FY26 Results

When did Arunjyoti Bio Ventures announce Q4 FY26 results?

Ans. Arunjyoti Bio Ventures announced Q4 FY26 results on May 13, 2026, through its board meeting and BSE/NSE exchange filings.

What are the key highlights of Arunjyoti Bio Ventures Q4 FY26?

Ans. Arunjyoti Bio Ventures Q4 FY26 standalone net sales were Rs 7.24 crore, up 37.04% YoY from approximately Rs 5.28 crore in Q4 FY25. The company develops and markets biofertilizers and biopesticides for…

Where can I track Arunjyoti Bio Ventures Q4 FY26 live data?

Ans. Track Arunjyoti Bio Ventures live price, analyst ratings, and Q4 FY26 earnings on the Univest Screener for real-time data and research.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. All financial data cited is sourced from BSE/NSE exchange filings and verified news sources. Investments in securities are subject to market risk. Consult a SEBI-registered investment advisor before making any investment decision.



News Q4 Results
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply